209 related articles for article (PubMed ID: 15743806)
1. Bruton's tyrosine kinase regulates immunoglobulin promoter activation in association with the transcription factor Bright.
Rajaiya J; Hatfield M; Nixon JC; Rawlings DJ; Webb CF
Mol Cell Biol; 2005 Mar; 25(6):2073-84. PubMed ID: 15743806
[TBL] [Abstract][Full Text] [Related]
2. Induction of immunoglobulin heavy-chain transcription through the transcription factor Bright requires TFII-I.
Rajaiya J; Nixon JC; Ayers N; Desgranges ZP; Roy AL; Webb CF
Mol Cell Biol; 2006 Jun; 26(12):4758-68. PubMed ID: 16738337
[TBL] [Abstract][Full Text] [Related]
3. The transcription factor Bright associates with Bruton's tyrosine kinase, the defective protein in immunodeficiency disease.
Webb CF; Yamashita Y; Ayers N; Evetts S; Paulin Y; Conley ME; Smith EA
J Immunol; 2000 Dec; 165(12):6956-65. PubMed ID: 11120822
[TBL] [Abstract][Full Text] [Related]
4. Transcription factor STAT5A is a substrate of Bruton's tyrosine kinase in B cells.
Mahajan S; Vassilev A; Sun N; Ozer Z; Mao C; Uckun FM
J Biol Chem; 2001 Aug; 276(33):31216-28. PubMed ID: 11413148
[TBL] [Abstract][Full Text] [Related]
5. Identification of phosphorylation sites for Bruton's tyrosine kinase within the transcriptional regulator BAP/TFII-I.
Egloff AM; Desiderio S
J Biol Chem; 2001 Jul; 276(30):27806-15. PubMed ID: 11373296
[TBL] [Abstract][Full Text] [Related]
6. Bruton's tyrosine kinase (Btk) enhances transcriptional co-activation activity of BAM11, a Btk-associated molecule of a subunit of SWI/SNF complexes.
Hirano M; Kikuchi Y; Nisitani S; Yamaguchi A; Satoh A; Ito T; Iba H; Takatsu K
Int Immunol; 2004 May; 16(5):747-57. PubMed ID: 15096481
[TBL] [Abstract][Full Text] [Related]
7. Regulation of nuclear localization and transcriptional activity of TFII-I by Bruton's tyrosine kinase.
Novina CD; Kumar S; Bajpai U; Cheriyath V; Zhang K; Pillai S; Wortis HH; Roy AL
Mol Cell Biol; 1999 Jul; 19(7):5014-24. PubMed ID: 10373551
[TBL] [Abstract][Full Text] [Related]
8. Transgenic mice expressing dominant-negative bright exhibit defects in B1 B cells.
Nixon JC; Ferrell S; Miner C; Oldham AL; Hochgeschwender U; Webb CF
J Immunol; 2008 Nov; 181(10):6913-22. PubMed ID: 18981111
[TBL] [Abstract][Full Text] [Related]
9. Mutations in the DNA-binding domain of the transcription factor Bright act as dominant negative proteins and interfere with immunoglobulin transactivation.
Nixon JC; Rajaiya J; Webb CF
J Biol Chem; 2004 Dec; 279(50):52465-72. PubMed ID: 15456761
[TBL] [Abstract][Full Text] [Related]
10. The transcription factor, Bright, and immunoglobulin heavy chain expression.
Webb CF
Immunol Res; 2001; 24(2):149-61. PubMed ID: 11594453
[TBL] [Abstract][Full Text] [Related]
11. Bruton's tyrosine kinase is essential for hydrogen peroxide-induced calcium signaling.
Qin S; Chock PB
Biochemistry; 2001 Jul; 40(27):8085-91. PubMed ID: 11434777
[TBL] [Abstract][Full Text] [Related]
12. Signalling of the BCR is regulated by a lipid rafts-localised transcription factor, Bright.
Schmidt C; Kim D; Ippolito GC; Naqvi HR; Probst L; Mathur S; Rosas-Acosta G; Wilson VG; Oldham AL; Poenie M; Webb CF; Tucker PW
EMBO J; 2009 Mar; 28(6):711-24. PubMed ID: 19214191
[TBL] [Abstract][Full Text] [Related]
13. The transcription factor, Bright, is not expressed in all human B lymphocyte subpopulations.
Nixon JC; Rajaiya JB; Ayers N; Evetts S; Webb CF
Cell Immunol; 2004 Mar; 228(1):42-53. PubMed ID: 15203319
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of Bruton's tyrosine kinase-mediated recruitment and regulation of TFII-I.
Sacristán C; Tussié-Luna MI; Logan SM; Roy AL
J Biol Chem; 2004 Feb; 279(8):7147-58. PubMed ID: 14623887
[TBL] [Abstract][Full Text] [Related]
15. Bruton's tyrosine kinase is a Toll/interleukin-1 receptor domain-binding protein that participates in nuclear factor kappaB activation by Toll-like receptor 4.
Jefferies CA; Doyle S; Brunner C; Dunne A; Brint E; Wietek C; Walch E; Wirth T; O'Neill LA
J Biol Chem; 2003 Jul; 278(28):26258-64. PubMed ID: 12724322
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the Bruton's tyrosine kinase gene promoter reveals critical PU.1 and SP1 sites.
Himmelmann A; Thevenin C; Harrison K; Kehrl JH
Blood; 1996 Feb; 87(3):1036-44. PubMed ID: 8562928
[TBL] [Abstract][Full Text] [Related]
17. REKLES is an ARID3-restricted multifunctional domain.
Kim D; Probst L; Das C; Tucker PW
J Biol Chem; 2007 May; 282(21):15768-77. PubMed ID: 17400556
[TBL] [Abstract][Full Text] [Related]
18. Cell specific expression of human Bruton's agammaglobulinemia tyrosine kinase gene (Btk) is regulated by Sp1- and Spi-1/PU.1-family members.
Müller S; Sideras P; Smith CI; Xanthopoulos KG
Oncogene; 1996 Nov; 13(9):1955-64. PubMed ID: 8934542
[TBL] [Abstract][Full Text] [Related]
19. Phosphatidylinositol 3-kinase-gamma activates Bruton's tyrosine kinase in concert with Src family kinases.
Li Z; Wahl MI; Eguinoa A; Stephens LR; Hawkins PT; Witte ON
Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13820-5. PubMed ID: 9391111
[TBL] [Abstract][Full Text] [Related]
20. Dual phosphorylation of Btk by Akt/protein kinase b provides docking for 14-3-3ζ, regulates shuttling, and attenuates both tonic and induced signaling in B cells.
Mohammad DK; Nore BF; Hussain A; Gustafsson MO; Mohamed AJ; Smith CI
Mol Cell Biol; 2013 Aug; 33(16):3214-26. PubMed ID: 23754751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
